RBFOX1 and epilepsy: Abnormal reduction of Rbfox1/2 (A2BP1) was reported in a subset of ASD patients [39] and copy number variation (CNV) analysis disrupting A2BP1 (or Rbfox1) have been reported in patients with autism, schizophrenia, epilepsy and mental retardation [40–44].